Diabetic kidney disease: from pathogenesis to multimodal therapy-current evidence and future directions. [PDF]
Zhang H +7 more
europepmc +1 more source
A Review on Biodegradable Materials of Sustainable Soft Robotics and Electronics
Biodegradable materials are gaining increasing attention in soft robotics and electronics due to their environmental friendliness, showing great potential for sustainability. In this review, the classification of biodegradable materials, their applications in the field of soft robotics and electronics, as well as the challenges and future prospects ...
Yizhu Xie +8 more
wiley +1 more source
Correction to "Farber's Lipogranulomatosis: Multimodal Therapy With Tocilizumab and Consolidative HSCT Improves Assessment, and Long-Term Outcome". [PDF]
europepmc +1 more source
Partial Response to Sintilimab-Based Multimodal Therapy in a Refractory Primary Mediastinal Yolk Sac Tumor: A Case Report. [PDF]
Sun Y, Li X, Yang M, He C.
europepmc +1 more source
Customizable, programmable, multimodal ophthalmic laser platform: towards improved therapy
Suzie Dufour +5 more
openalex +1 more source
Nanodynamic therapy for cancer: mechanistic innovations, targeting strategies and multimodal treatments [PDF]
Yuyang Li +12 more
openalex +1 more source
Precise Regulation of Membrane Proteins: From Physical Technology to Biomolecular Strategy
This review summarizes the emerging strategies for the precise regulation of membrane proteins using physical stimuli and biomolecule‐based tools. These methods provide new insights into cell regulation and offer promising directions for future disease treatment.
Xiu Zhao +6 more
wiley +1 more source
Pathology-tailored nanotherapy via Galectin-3-targeted and triple-responsive nanoparticles enables multimodal therapy against aortic dissection. [PDF]
Lin C +10 more
europepmc +1 more source
PARPi Combining Nanoparticle LIN28B siRNA for the Management of Malignant Ascites
This study demonstrates that co‐inhibition of LIN28B and PARP using siLin28b/DSSP@lip‐PEG‐FA nanoparticles in combination with the PARP inhibitor BMN673 effectively suppresses the accumulation of malignant ascites associated with advanced cancers.
Yan Fang +13 more
wiley +1 more source
Precision oncology for advanced oral cancer: synergizing multimodal therapy with dynamic biomarker monitoring. [PDF]
Zhang J, Dong G, Fu TG.
europepmc +1 more source

